Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.
Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those interested in joining the study, along with a reference to the Contacts and Locations section in the How to Read a Study Record.SummaryDifference1%
- Check53 days agoChange DetectedThe website has removed several links related to genetics and multiple myeloma, as well as various drug information pages, while adding a 'Show less' feature.SummaryDifference2%
- Check60 days agoChange DetectedThe website has been updated to version v2.12.2, with new links added for multiple myeloma resources, clinical trials, and drug information, while the previous version v2.12.1 has been removed.SummaryDifference2%
- Check75 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.0%
Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.